HomeAbout

TL;DR CNBC


Aradhana Sarin - TL;DR CNBC

Aradhana Sarin

Publishing timestamp: 2024-02-28 05:54:02


Summary

AstraZeneca's CFO Aradhana Sarin has led deals to expand the company's drug pipeline and embrace technology to advance modern medicine. The company launched its health-tech division Evinova in November 2023, focusing on digital technology to develop clinical trials and medicine delivery. AstraZeneca also acquired preclinical gene therapy programs from Pfizer, with a focus on rare diseases. Sarin, a former medical doctor with an MBA from Stanford, believes gene therapy and other technologies will be crucial in the future of medicine.


Sentiment: POSITIVE

Tickers: AZNAZN-GB

Keywords: business newsexclude from automated curationmediaastrazeneca plcscience

Source: https://www.cnbc.com/2024/02/28/aradhana-sarin-cnbc-changemakers.html


Developed by Leo Phan